baber/WOPTO huggingface dataset:
Patent NZ-536786-A (NZ)
Title: Method for generating immune-compatible cells and tissues using nuclear transfer techniques
Inventor: LANZA ROBERT
IPC: A61K35/12
Filed: 2000-09-06
Abstract: Disclosed herein is a method of testing the immune compatibility of cloned cells or tissues in a non-human donor animal that comprises: (a) providing a cell from said non-human donor animal; (b) transferring the nucleus from said cell into a non-human recipient oocyte or other suitable non-human recipient cell to generate an embryo; (c) isolating at least one inner cell mass, at least one embryonic disk and/or at least one stem cell from said embryo; (d) injecting at least one of said inner cell masses, at least one of said embryonic discs, and/or at least one of said stem cells into said non-human donor animal at the same time as at least one non-human control embryonic disk and/or at least one non-human control stem cell is injected into said non-human donor animal; and (e) examining at least one of the injection sites for teratoma formation.
Patent NZ-539203-A (NZ)
Title: Methods for regulating cancer
Inventor: STEPHENSON SALLY-ANNE
IPC: C12N5/09
Filed: 2003-09-16
Abstract: Disclosed are methods for inhibiting cancerous growth of a cell using an antibody or an antigen-binding portion thereof which binds to an epitope of EphB4 polypeptide. Purified antibodies of EphB4 are also provided. Also disclosed are methods of identifying agents that can inhibit cancerous growth of a cell.
Patent NZ-543201-A (NZ)
Title: Lactate containing pharmaceutical composition and uses thereof
Inventor: LEVERVE XAVIER M
IPC: A23L33/00
Filed: 2004-03-22
Abstract: Disclosed is the use of a composition containing 250 to 2400 millimoles per litre of L-lactic acid or L-lactate, and 2 to 10 millimoles per litre of potassium, for the manufacture of a pharmaceutical composition for the treatment of brain edema, wherein the brain edema is caused by traumatic or non traumatic brain injury.
Patent NZ-543326-A (NZ)
Title: Rotating piston machine in which the piston rotates about two parallel axes of rotation
Inventor: ZELEZNY EDUARD
IPC: F01C17/00
Filed: 2004-03-25
Abstract: A machine with a rotary piston is disclosed. The rotary piston is mounted between two side walls and a curved circumferential wall of a cylinder in a rotating way around two parallel axes of rotation. The axes of rotation are normal to the side walls of the cylinder, and in a sliding way in two directions normal to the axes of rotation and to one another. The rotary piston circumscribing in the cylinder workspaces that have periodically varying volume. The rotary piston is provided with an inboard sliding element having guiding surfaces wherein: (a) the rotary piston is supported by guiding surfaces on a guide ring, and the guide ring is pivoted in the sidewall in a rotating way around the axis of rotation, (b) the guide ring is provided with a bore, a supporting shaft passing through the bore, and (c) the rotary piston is further supported on the supporting shaft for a sliding movement normal to the axis of the supporting shaft or in a rotating way on a supporting eccentric firmly connected with the supporting shaft.
Patent NZ-546632-A (NZ)
Title: Interleukin-10 antibodies
Inventor: PRESTA LEONARD G
IPC: G01N33/68
Filed: 2004-11-09
Abstract: Disclosed are recombinant antibody molecules that bind lL-1 0 or binding fragments thereof, comprising: at least one antibody light chain variable region, or binding fragment thereof, comprising a polypeptide having at least one amino acid sequence selected from the group consisting of SEQ ID NO:1 at CDR1, SEQ ID NO:2 at CDR2, and SEQ ID NO:3 at CDR3; and at least one antibody heavy chain variable region, or binding fragment thereof, comprising a polypeptide having at least one amino acid sequence selected from the group consisting of SEQ ID NO:6 at CDR1, SEQ ID NO:7 at CDR2, and SEQ ID NO:8 at CDR3. The antibodies are useful for suppressing an immune response.
Patent NZ-549010-A (NZ)
Title: Hyaluronic acid derivative and drug containing the same
Inventor: MIYAMOTO KENJI
IPC: A61P29/00
Filed: 2005-01-07
Abstract: Disclosed is non-steroidal anti-inflammatory (NSAID) drug bound to hyaluronic acid through a covalent bond, represented by the following formula: Y-CO-NH-R1-(O-R2)n wherein Y-CO- represents one residue of the hyaluronic acid disaccharide unit; R2 represents an NSAID residue represented by Z-CO- or hydrogen, with the proviso that all R2 are not hydrogen; wherein R2 is Z-CO, HNR1-(OR2) is -HN-R1-(O-CO-Z), wherein -O-CO- represents an ester bond of a hydroxyl group in the spacer compound and a carboxyl group in the non-steroidal anti-inflammatory residue; -HN-R1-(O-)n represents a spacer residue in a spacer compound represented by H2N-R1( OH)n having n numbers of a hydroxyl group; R1 represents a linear or branched hydrocarbon group having from 2 to 12 carbon atoms which may have a substituent; n is an integer of from 1 to 3, wherein the hyaluronic acid derivative has a degree of substitution of the NSAID of from 5 to 50 mol % per repeating disaccharide unit of hyaluronic acid, and the carbonyl group in a hyaluronic acid residue constituting the hyaluronic acid derivative is present as an amide bond participating in the binding with the spacer-binding anti-inflammatory drug residue or as a free carboxyl group not participating therein, according to the degree of substitution of the non-steroidal anti-inflammatory drug residue. Also disclosed is an intermediate represented by the following formula: H2N-R1-(O-R2)n wherein R2 represents hydrogen or an NSAID residue represented by Z-CO-, with the proviso that all R2 are not hydrogen; R1 represents a linear or branched hydrocarbon group having from 2 to 12 carbon atoms which may have substituents; and n is an integer of from 1 to 3.
Patent NZ-565294-A (NZ)
Title: Compositions of tRNA and uses thereof
Inventor: TIAN FENG
IPC: C12N15/12
Filed: 2005-12-01
Abstract: Provided is a transfer RNA having a specified nucleotide sequence, useful in producing a polypeptide comprising a selected amino acid at a specified position in a translation system including an orthogonal amino-acyl-tRNA synthetase. Further provided are vectors and methods of using the tRNA.
Patent NZ-577472-A (NZ)
Title: Rfid label with coupling antenna and carrier film
Inventor: BOHN MARTIN
IPC: H01L23/498
Filed: 2007-10-16
Abstract: Disclosed is a self-adhesive label (1) made of an RFID chip (3) and a coupling antenna (4) on a carrier film (5). The RFID chip (3) is fixed directly onto and galvanically connected to the coupling antenna (4). The RFID chip (3) and coupling antenna (4) are arranged in a plane with the carrier film (5). The underside of the label (1) has an adhesive layer covered by a strippable web- or sheet-type separating material. This layer is located on the carrier film (5). The thicknesses of the carrier film (5) and adhesive layer are set so that, when the label (1) is attached to an additional RFID antenna (6), the coupling antenna (4) and the additional RFID antenna (6) are inductively coupled. The label (1) can be attached to the additional RFID antenna (6) by adhesive bonding using the adhesive layer.
Patent NZ-584738-A (NZ)
Title: Portable handheld liquid pumping and removal device
Inventor: METCALFE COLIN
IPC: F04D29/28
Filed: 2008-10-15
Abstract: A portable hand held controllable and directable liquid pumping device comprising a vortex pump head (1) fitted to a first end (2) of an elongate flexible drive shaft (3) and a pump driving means (4) fitted to a second end (5) of the flexible drive shaft wherein said pump driving means includes a substantially rigid elongate housing (6) for a portion of the drive shaft and wherein said elongate housing including a first handle means (7) at or near the first end (8) remote from said pump driving means.
Patent NZ-593986-A (NZ)
Title: Compositions comprising a protein and a carrier for topical diagnostic and therapeutic transport
Inventor: DAKE MICHAEL D
IPC: A61K47/48
Filed: 2005-03-03
Abstract: Patent No. 593986 Disclosed is a composition comprising a biologically active protein which is not insulin nor vascular endothelial growth factor (VEGF) and a positively charged carrier present in an effective amount for transdermal delivery, the positively charged carrier comprising a positively charged polymeric backbone having attached thereto amino acid sequences selected from the group consisting of -(gly)nl-(arg)n2, (gly)p-RGRDDRRQRRR-(gly)q , (gly)p-YGRKKRRQRRR-(gly)q, (gly)p-RKKRRQRRR-(gly)q and Antennapedia protein transduction domain (PTD); wherein the subscript n1 is an integer of from 0 to 20, and the subscript n2 is independently an odd integer of from 5 to 25, wherein the subscripts p and q are each independently an integer of from 0 to 20, wherein the positively charged polymeric backbone is a polypeptide that promotes transdermal delivery of the biologically active protein; wherein the biologically active protein is not modified by covalent attachment to a negatively charged backbone; and wherein the positively charged carrier and the biologically active protein directly contact to form a non-covalent complex.
Patent NZ-594234-A (NZ)
Title: Beverage having milk flavour and low protein and fat content
Inventor: KOMATSU KOHEI
IPC: A23L29/00
Filed: 2010-03-02
Abstract: 594234 BEVERAGE HAVING MILK FLAVOUR AND LOW PROTEIN AND FAT CONTENT Provided is a milk-flavoured beverage comprising whey mineral and a sweetener and containing 0.3% by mass or less of protein and 0.3% by mass or less of fat and oil, wherein, the whey mineral is present in an amount of 0.1% to 5% by mass on a solid basis, the whey mineral having an ash content of at least 30% relative to the solids content of the whey mineral, and wherein the whey mineral has a calcium content of less than 2% by mass relative to the solids content of the whey mineral.
Patent NZ-597095-A (NZ)
Title: Floor profile arrangement with profile strip with retaining device
Inventor: SONDERMANN FRANK
IPC: E04F19/06
Filed: 2010-06-10
Abstract: Patent 597095
Patent NZ-598101-A (NZ)
Title: Imrpoved screen panel
Inventor: MOHANKA MADAN MOHAN
IPC: B07B1/46
Filed: 2009-11-05
Abstract: A screen panel for mining and quarrying industries adapted to be mounted on a screen deck, including a screening surface made up of materials such as herein described formed on a reinforcing frame, said screening surface having suitably designed apertures of desired shape for allowing materials of desired size to pass through, said apertures having walls (2) made of abrasion resistant material such as herein described, whereby retention of said desired shape of said apertures is ensured for a substantially long period of time.
Patent NZ-602127-A (NZ)
Title: Method for measuring crop cultivation frequency of soil and method for assessing production region deception
Inventor: HATANO SHOJI
IPC: C12Q1/02
Filed: 2010-02-01
Abstract: 602127 Disclosed is a method for testing soil by means of biological methods using microorganisms that inhabit the soil to be tested. In addition, the authenticity of the production region of an agricultural product is determined from the soil adhered thereto. Specifically disclosed is a method for measuring the crop cultivation frequency of soil, which comprises a sample generation step for generating a suspension of soil to be measured as a micro-organism sample; a dropping step for dropping the suspension, which is the generated microorganism sample, into a plurality of nutrient sources in which the consumption rates of at least a portion thereof differ depending on the microorganism species; and an observation step for observing the cumulative consumption rate of each nutrient source by the microorganisms after dropping. In addition, the authenticity of the production region label is assessed by comparing the soil adhered to the agricultural product to soil from the production region on the label.
Patent NZ-602693-A (NZ)
Title: Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
Inventor: GRANDI GUIDO
IPC: C07K16/12
Filed: 2011-04-01
Abstract: Disclosed is a polypeptide comprising at least two of: a)a first polypeptide comprising a first amino acid sequence consisting of a fragment of SEQ ID NO: 1 comprising an amino acid sequence set forth in SEQ ID NO: 10 (D3), SEQ ID NO: 36 (D3 sub-fragment), SEQ ID NO: 51 (D3+D4H) or SEQ ID NO: 53 (D2+D3+D4H); b)a second polypeptide comprising a second amino acid sequence consisting of a fragment of SEQ ID NO: 2 comprising an amino acid sequence set forth in SEQ ID NO: 14 (D3), SEQ ID NO: 38 (D3 sub-fragment), SEQ ID NO: 55 (D3+D4H) or SEQ ID NO: 57 (D2+D3+D4H); c)a third polypeptide comprising a third amino acid sequence consisting of fragment of SEQ ID NO: 3 comprising an amino acid sequence set forth in SEQ ID NO: 18 (D3), SEQ ID NO: 40 (D3 sub-fragment), SEQ ID NO: 59 (D3+D4H) or SEQ ID NO: 61 (D2+D3+D4H); d)a fourth polypeptide comprising a fourth amino acid sequence consisting of a fragment of SEQ ID NO: 4 comprising an amino acid sequence set forth in SEQ ID NO: 22 (D3), SEQ ID NO: 42 (D3 sub-fragment), SEQ ID NO: 63 (D3+D4H) or SEQ ID NO: 65 (D2+D3+D4H); e)a fifth polypeptide comprising a fifth amino acid sequence consisting of a fragment of SEQ ID NO: 5 comprising an amino acid sequence set forth in SEQ ID NO: 26 (D3), SEQ ID NO: 44 (D3 sub-fragment), SEQ ID NO: 67 (D3+D4H) or SEQ ID NO: 69 (D2+D3+D4H); f)a sixth polypeptide comprising a sixth amino acid sequence consisting of a fragment of SEQ ID NO: 6 comprising an amino acid sequence set forth in SEQ ID NO: 30 (D3), SEQ ID NO: 46 (D3 sub-fragment), SEQ ID NO: 71 (D3+D4H) or SEQ ID NO: 73 (D2+D3+D4H); and g)a seventh polypeptide comprising a seventh amino acid sequence consisting of a fragment of SEQ ID NO: 7 comprising an amino acid sequence set forth in SEQ ID NO: 34 (D3), SEQ ID NO: 48 (D3 sub-fragment), SEQ ID NO: 75 (D3+D4H) or SEQID NO: 77 (D2+D3+D4H), wherein the sequences are as defined in the complete specification. Also disclosed is the use of said polypeptide in the manufacture of a medicament for treatment or prevention of Group B Streptococcus infection and/or a disease caused by GBS infection in a mammal.
Patent NZ-606099-A (NZ)
Title: Urethane modified water-reducible alkyd resin compositions
Inventor: REIDLINGER GERHARD DR
IPC: C08G18/42
Filed: 2011-07-24
Abstract: Disclosed is an aqueous coating composition comprising a combination of a high molar mass urethane-modified alkyd resin and a reactive diluent, characterised in that the alkyd resin has moieties derived from grafted fatty acids which are graft products of fatty acids having at least one olefinic unsaturation, on average, per molecule, and olefinically unsaturated linear or branched aliphatic acids preferably having from three to ten carbon atoms, polyhydric aliphatic alcohols, fatty acids and polyfunctional isocyanates, and the reactive diluent has a hydroxyl number of at most 5 mg/g, and comprises moieties derived from olefinically unsaturated fatty acids, and polyoxyalkylene glycols or their monoethers, to a process of preparation thereof, and a method of use thereof for coating of wood, fibreboard, textiles, paper, cardboard, leather, and thermoplastic materials.
Patent NZ-609056-A (NZ)
Title: Operating table with multiple degrees of freedom
Inventor: SUN ZHUBIN
IPC: B25H1/18
Filed: 2012-05-18
Abstract: An operating table (6) capable of moving and rotating in X, Y and Z directions as well as tilting includes an elevating mechanism, a moving mechanism on a horizontal plane and a multiple angle rotation mechanism. The elevating mechanism and the moving mechanism utilise a leadscrew structure, and the multiple angle rotation mechanism comprises a universal joint device (7) and a locking mechanism. A moving mechanism can drive the operating table (6) to move on a horizontal plane. The moving mechanisms in the X and Y directions can operate separately as well as cooperatively, and the multiple angle rotation mechanism drives the surface of the operating table to tilt.
Patent NZ-609363-A (NZ)
Title: Methods for determining anti-drug antibody isotypes
Inventor: WANG SHUI LONG
IPC: G01N33/68
Filed: 2011-10-18
Abstract: Disclosed is a method for detecting the presence or level of a plurality of at least two, three, four, five or more isotypes of an autoantibody to an anti-TNFα drug in a sample, the method comprising: (a) contacting a labeled anti-TNFα drug with a sample having or suspected of having at least one isotype of an autoantibody to the anti-TNFα drug to form labeled complexes between the labeled anti-TNFα drug and each autoantibody isotype; (b) subjecting the labeled complexes to size exclusion chromatography to separate the labeled complexes having different autoantibody isotypes from each other and from free labeled anti-TNFα drug; and (c) detecting the labeled complexes, thereby detecting the presence or level of a plurality of at least two, three, four, five or more isotypes of the autoantibody to the anti-TNFα drug. Further disclosed is a method for detecting the presence or level of at least one isotype of an autoantibody to an anti-TNFα drug in a sample, the method comprising: (a) contacting a labeled anti-TNFα drug and one or a plurality of labeled anti-Ig antibodies specific for different antibody isotypes with a sample having or suspected of having at least one isotype of an autoantibody to the anti-TNFα drug to form labeled complexes between the labeled anti-TNFα drug, the labeled anti-Ig antibodies, and each autoantibody isotype, wherein the labeled anti-TNFα drug and the labeled anti-Ig antibodies comprise different labels; (b) subjecting the labeled complexes to size exclusion chromatography to separate the labeled complexes having different autoantibody isotypes from each other, from free labeled anti-TNFα drug, and/or from free labeled anti-Ig antibodies; and (c) detecting the labeled complexes, thereby detecting the presence or level of at least one isotype of the autoantibody to the anti-TNFα drug.
Patent NZ-614529-A (NZ)
Title: Barrier system
Inventor: HAYDEN WALLACE
IPC: E01F15/00
Filed: 2013-08-20
Abstract: 614529 A barrier system including a guardrail, a support (3) to hold the guardrail in position and a fastener to attach the guardrail to the support is disclosed. The support has a weakened zone (16), around an aperture (13) for the fastener, to facilitate the fastener releasing from the support when the support is subject to impact forces. The zone may immediately release the fastener or initially deform a section (20) of the support delimited by the zone, then release that section. A number of zone shapes and configurations are disclosed.
Patent NZ-617764-A (NZ)
Title: Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
Inventor: TZORTZIS GEORGIOS
IPC: C07H3/06
Filed: 2012-06-20
Abstract: The disclose relates to the use of a mixture of galactooligosaccharides which comprises disaccharides Gal(B1-3)-Glc; Gal (B1-3)-Gal; Gal (B1-6)-Gal; Gal (a1-6)-Gal; 5 trisaccharides Gal (B1-6)-Gal (B1-4)-Glc; Gal (B1-3)-Gal (B1-4)-Glc; tetrasaccharide Gal (B1-6)-Gal (B1-6)-Gal (B1-4)-Glc and pentasaccharide Gal (B1-6)-Gal (B1-6)-Gal (B1-6)Gal (B1-4)-Glc for use in preventing or reducing the risk of developing metabolic syndrome or lowering cholesterol and triglyceride levels in the blood.
Patent NZ-621991-A (NZ)
Title: Heterocyclylamines as pi3k inhibitors
Inventor: ZHU WENYU
IPC: C07D487/04
Filed: 2012-08-31
Abstract: Provided are bicyclic heterocyclylamine derivative compounds, of the general formula I, wherein the variables are as defined in the specification. Examples of the compounds include 1-{ 1-[5-Chloro-3-(1-isopropylazetidin-3-yl)-2-methoxy-4-methylphenyl)ethyl} -3-methyl-1H-pyrazolo[3,4-d)pyrimidin-4-amine bis(trifluoroacetate) and 5-{ 3-[1-(4-Amino-6-methyl-5-oxopyrido[2,3-d)pyrimidin-8(5H)-yl)ethyl)-5-chloro-2-methoxy-6-methylphenyl} -N,N-dimethylpyridine-2-carboxamide bis(trifluoroacetate). The compounds are inhibitors of phosphoinositide 3-kinases (PI3Ks). The compounds are useful in the treatment of cancer, inflammatory diseases and immune diseases.
Patent NZ-626654-A (NZ)
Title: Energy recovery in manufacture of sulfuric acid
Inventor: VERA-CASTANEDA ERNESTO
IPC: C01B17/765
Filed: 2011-01-20
Abstract: Disclosed herein is a process for the preparation of sulfuric acid comprising: burning sulfur in a dry gas comprising excess oxygen in a combustion zone to produce a sulfur oxide-bearing gas stream comprising a combustion gas comprising sulphur dioxide, oxygen and not more than 0.005 moles water vapor per mole SO2; contacting the sulfur oxide-bearing gas stream comprising said combustion gas with a catalyst for conversion of sulfur dioxide to sulfur trioxide, thereby converting the sulfur oxide-bearing gas stream to a conversion gas containing not more than 0.005 moles water vapor per mole SO3; contacting the conversion gas in a primary heat recovery absorption zone with an absorption liquid comprising sulfuric acid, thereby transferring sulfuric acid from the conversion gas to the absorption liquid; introducing water vapor into the conversion gas into a water vapor injection zone upstream of the primary heat recovery absorption zone with respect to the direction of gas flow in a proportion sufficient to increase the equivalent water vapor content of the gas to at least about 0.55 moles per mole total equivalent sulfur oxide gas content prior to entry of the gas stream into the primary absorption zone; and circulating said absorption liquid between said primary absorption zone and an indirect heat exchanger in which heat generated by reaction of sulfur trioxide and water, condensation of sulphuric acid, and/or absorption of sulphur trioxide into the absorption liquid is transferred to a heat transfer fluid, thereby heating the heat transfer fluid to at least 150°C.
Patent NZ-707199-A (NZ)
Title: Power driven vehicle having a take-apart frame
Inventor: HOFFMANN DIRK
IPC: B62K15/00
Filed: 2012-11-30
Abstract: The present invention relates to a power driven vehicle used by at least partially disabled persons for mobility, having a two-part frame assembly in which the mechanism used for assembling and disassembling said assembly is easy to handle, may be actuated using one hand, limits the steps involving during the assembly and disassembly action, and which the user can easily know if the two-part frame is correctly and safely disassembled. The present invention therefore enables the user to facilitate ease and storage of said vehicle and further addresses the problems of the prior art such as difficulty in handling during assembly and disassembly of prior art frames, the use of both hands required, and insecure assembly and locking of frames. The vehicle comprising: a frame (202, 302) having a front frame (221, 321) and a rear frame (222, 322) that are detachably and pivotally connected together, said front frame (221, 321) comprising means (207b) for receiving at least one steerable wheel and a steering mechanism and means (207a, 307a) for receiving a seat, and said rear frame (222, 322) comprising means (226a, 226b) for receiving at least two drive wheels; at least one steerable wheel, a steering mechanism and a seat connected to said front frame (221, 321); at least two drive wheels pivotally connected to said rear frame (222, 322) via a single axle; an electric motor mounted on said rear frame (222, 322) and adapted to drive at least one of said drive wheels; a shroud (204, 304) covering at least partially said front frame (221, 321) and fixedly connected thereto; at least one battery box (205, 305) detachably mounted on said shroud (204, 304) and in electrical communication with said electric motor; locking/unlocking means (230, 330) adapted to prevent, or respectively permit, the disconnection of said rear frame (222, 322) from said front frame (221, 321).